Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029

Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization

RELEASE DATE
10-Sep-2024
REGION
Global
Deliverable Type
Market Research
Research Code: PFOW-01-00-00-00
SKU: HC_2024_1002
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_1002

Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Published on: 10-Sep-2024 | SKU: HC_2024_1002

Need more details?
$4,950.00
DownloadLink
Need more details?

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across geographies, pharma companies are collaborating with third-party logistics and adopting adaptive supply chain strategies, such as dual sourcing, stockpiling, and advanced scenario planning, while tapping into established distribution partners' capabilities to avoid distribution risks and disruptions. As a result, marketing and sales strategies are designed to allow pharma companies to navigate the sea of stakeholders, regulatory bodies, end users, and other technology vendors. To increase product awareness and subsequent uptake, pharma marketing creates a positive image and confidence amongst HCPs for drug adoption using scientific data, testimonials, and many more. Pharma companies will have to adopt a step-by-step approach toward commercial market access, which involves everything from identifying the target market based on the product value proposition to understanding changes in end-user perspective and making the necessary alterations to maintain a competitive edge. Automation and the use of AI, ML, and cloud solutions will be instrumental in upscaling pharma commercial operations. These tools use predictive analytics for market segmentation, content personalization, lead identification and scoring, and subsequent market access, thereby ensuring better product uptake and revenue. Pharma companies and vendors must look at industry cross-collaborations that will improve commercialization success. This analysis dives deep into market opportunities available in HEOR solutions, tailormade/precision omnichannel marketing strategies, and integrated drug pricing for payers and PBMs and categorizes forecasts by service model/agreement type.

Author: Aarti Siddhesh Chitale

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Pharmaceutical Commercial Solutions and Services Industry

Scope of Analysis

Market Definition, Scope and Segmentation

Segmentation by Commercial Services Model/Partnership Type

Pharmaceutical Commercial Value Chain—Commercial Analytics Overview

Market Trend Analysis

Market Trend Analysis (continued)

Market Trend Analysis (continued)

Growth Drivers

Growth Restraints

Pharmaceutical Commercial Launch—Primary Operations and Stakeholders involved

Key Aspects of Pharmaceutical Marketing and Sales

Key Aspects of Pharmaceutical Market Access Process

Vendor Ecosystem

Digital Solutions for Commercialization by Stakeholders

Technology Application across Pharma Commercial Activities

AI Application across the Commercialization Value Chain

Digital Marketing Strategies for Effective Communication

Digital Market Access Strategies

Embracing Digital Transformation for Patient-centric Pharma Commercialization

Investment Trends

Investment Trends—Technology Acquisition/Partnerships

Investment Trends—Technology Acquisition/Partnerships (continued)

Investment Trends—Technology Acquisition/Partnerships (continued)

Investment Trends—Strategic Partnerships

Investment Trends—Strategic Partnerships (continued)

Investment Trends—Mergers & Acquisitions

New Product Launches—Expansions

New Product Launches—Expansions (continued)

New Product Launches—Expansions (continued)

New Product Launches—Expansions (continued)

New Product Launches—Expansions (continued)

Competitive Environment

Competitor Assessment: Pure Play

Competitor Assessment: CROs/CSOs

Competitor Assessment: Tech Enablers

Competitor Assessment

Competitor Assessment (continued)

Growth Metrics

Forecast Considerations: Approach and Methodology

Forecast Considerations: Approach and Methodology (continued)

Forecast Considerations: Approach and Methodology (continued)

Forecast Considerations: Limitations and Caveats

Forecast Considerations: Limitations and Caveats (continued)

Revenue Forecast

Revenue Forecast by Solution/Services Type

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Revenue Forecast Analysis (continued)

Revenue Forecast By Service Model/Agreement Type

Revenue Forecast Analysis By Service Model/Agreement Type

Revenue Forecast Analysis By Service Model/Agreement Type (continued)

Regional Trend Analysis—North America

Regional Trend Analysis—Europe

Regional Trend Analysis—Asia Pacific

Regional Trend Analysis—Other Emerging Markets

Growth Opportunity 1: Multi AI and LLM agents for HEOR Services

Growth Opportunity 1: Multi AI and LLM agents for HEOR Services (continued)

Growth Opportunity 2: Integrated Drug Pricing Strategies for PBMs and Payors

Growth Opportunity 2: Integrated Drug Pricing Strategies for PBMs and Payors (continued)

Growth Opportunity 3: Innovative Approaches for Precision Marketing and Sales Strategies

Growth Opportunity 3: Innovative Approaches for Precision Marketing and Sales Strategies (continued)

Best Practices Recognition

Frost Radar

Benefits and Impacts of Growth Opportunities

Next Steps

List of Exhibits

Legal Disclaimer

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market landscapes across geographies, pharma companies are collaborating with third-party logistics and adopting adaptive supply chain strategies, such as dual sourcing, stockpiling, and advanced scenario planning, while tapping into established distribution partners' capabilities to avoid distribution risks and disruptions. As a result, marketing and sales strategies are designed to allow pharma companies to navigate the sea of stakeholders, regulatory bodies, end users, and other technology vendors. To increase product awareness and subsequent uptake, pharma marketing creates a positive image and confidence amongst HCPs for drug adoption using scientific data, testimonials, and many more. Pharma companies will have to adopt a step-by-step approach toward commercial market access, which involves everything from identifying the target market based on the product value proposition to understanding changes in end-user perspective and making the necessary alterations to maintain a competitive edge. Automation and the use of AI, ML, and cloud solutions will be instrumental in upscaling pharma commercial operations. These tools use predictive analytics for market segmentation, content personalization, lead identification and scoring, and subsequent market access, thereby ensuring better product uptake and revenue. Pharma companies and vendors must look at industry cross-collaborations that will improve commercialization success. This analysis dives deep into market opportunities available in HEOR solutions, tailormade/precision omnichannel marketing strategies, and integrated drug pricing for payers and PBMs and categorizes forecasts by service model/agreement type. Author: Aarti Siddhesh Chitale
More Information
Deliverable Type Market Research
Author Aarti Siddhesh Chitale
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number PFOW-01-00-00-00